As of May 27
| -0.19 / -6.29%|
The 3 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 6.00, with a high estimate of 7.50 and a low estimate of 2.50. The median estimate represents a +112.01% increase from the last price of 2.83.
The current consensus among 3 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.